Autism overview

https://https://www.youtube.com/watch?v=_HGUyk5U_j8|350}}

Autism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autism overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autism overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autism overview

CDC on Autism overview

Autism overview in the news

Blogs on Autism overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Autism overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief:  Aditya Ganti M.B.B.S. [2] ; Syed Hassan A. Kazmi BSc, MD [3] ; Iqra Qamar M.D.[4] ;  Akshun Kalia M.B.B.S.[5] ; Sadaf Sharfaei M.D.[6] ; Chandrakala Yannam, MD [7]

## Overview

[edit | edit source]

Autism is a brain development disorder that impairs social interaction and communication, and causes restricted and repetitive behavior, all starting before a child is three years old. This set of signs distinguishes autism from milder autism spectrum disorders (ASD) such as Asperger syndrome. Autism has a strong genetic basis, although the genetics of autism are complex and it is unclear whether ASD is explained more by multigene interactions or by rare mutations. In rare cases, autism is strongly associated with agents that cause birth defects. Other proposed causes, such as childhood vaccines, are controversial and the vaccine hypotheses lack convincing scientific evidence. Most recent reviews estimate a prevalence of 100- 200 cases per 100,000 people for autism, and about 600 per 100,000 for ASD, with ASD averaging a 4.3:1 male-to-female ratio. The number of people known to have autism has increased dramatically since the 1980s, at least partially due to changes in diagnostic practice; the question of whether actual prevalence has increased is unresolved. Autism affects many parts of the brain; how this occurs is poorly understood. Parents usually notice signs in the first two years of their child's life. Early behavioral or cognitive intervention can help children gain self-care, social, and communication skills. There is no cure. Few children with autism live independently after reaching adulthood, but some become successful, and an autistic culture has developed, with some seeking a cure and others believing that autism is a condition rather than a disorder.

## Historical Perspective

[edit | edit source]

The first reported case of autism dates back to 1798, discovered by a medical student, Jean Itard, who treated the patient using a behavioral program. In 1943, Leo Kanner first described 11 cases of autism in his paper called autistic disturbances of affective contact. In 1910, Eugen Bleuler, a Swiss psychiatrist coined the term autism form latin word autismus. In 1981, Asperger was the first to separate Asperger syndrome, from autism.

## Classification

[edit | edit source]

DSM 5 categorized autism under autistic spectrum disorders/pervasive developmental disorders (PDD). Autistic spectrum of disorders are characterized by widespread abnormalities of social interactions, communication associated with severely restricted interests and repetitive behavior and can be classified into 5 types.

## Pathophysiology

[edit | edit source]

Despite extensive investigation, the occurrence of autism is not well understood. Its mechanism can be divided into two areas: the pathophysiology of brain structures and processes associated with autism, and the neuropsychological linkages between brain structures and behaviors.[1] The behaviors appear to have multiple pathophysiologies.

## Causes

[edit | edit source]

Autism and autism spectrum disorders are complex neuro developmental disorders. Many causes of autism have been proposed, but its theory of causation is still incomplete.[2] Heritability contributes about 90% of the risk of a child developing autism, but the genetics of autism are complex and typically it is unclear which genes are responsible.[3] In rare cases, autism is strongly associated with agents that cause birth defects.[4] Many other causes have been proposed, such as exposure of children to vaccines; these proposals are controversial and the vaccine hypotheses have no convincing scientific evidence.[5]

## Differentiating Autism from other Diseases

[edit | edit source]

Diagnosis of autism is based on behavior, but not cause or mechanism. Autism must be differentiated from other group of diseases with similar neurological presentations such as lack of social or emotional reciprocity, stereotyped and repetitive use of language or idiosyncratic language, and persistent preoccupation with parts of objects. Most common differential include Reitts disorders, other differentials include Leigh syndrome, Niemann-Pick disease type C, infantile muscle spasms.

## Epidemiology and Demographics

[edit | edit source]

Most recent reviews estimate a prevalence of 100- 200 cases per 100,000 people for autism, and about 600 per 100,000 for ASD, with ASD averaging a 4.3:1 male-to-female ratio. The number of people known to have autism has increased dramatically since the 1980s, at least partly due to changes in diagnostic practice; the question of whether actual prevalence has increased is unresolved.

## Risk Factors

[edit | edit source]

Common risk factors in the development of autism include male gender, advanced maternal and paternal age, low birth weight, hypoxia during childbirth, and family history schizophrenia.

## Screening

[edit | edit source]

The American Academy of Pediatrics recommends that all children be screened for ASD at the 18- and 24-months using autism-specific formal screening tests.

## Natural History, Complications and Prognosis

[edit | edit source]

ASD is a chronic illness with core features persisting throughout life, although presentation may vary according to the age, level of maturity, environment. Infantsare affected most severely. There is developmental delay and regression of language. Indifference and lack of interest (which is commonly found in ASD) may also seem like a delay in behavior. Some individuals may have a higher level of functioning despite social awkwardness (called savants). Autism patients may develop many syndromes and exhibit signs and symptoms of the respective syndrome, leading to complications. Higher socioeconomic status, acquisition of language skill at an early age, higher IQ and absence of underlying genetic or metabolic disorder are all associated with better outcomes in patients suffering from autism.

## Diagnosis

[edit | edit source]

### Diagnostic Criteria

[edit | edit source]

The diagnosis of autism is made on the basis of DSM-V Diagnostic Criteria for Autism Spectrum Disorder.

### History and Symptoms

[edit | edit source]

Autism is distinguished by a pattern of symptoms rather than one single symptom. The main characteristics are impairments in social interaction, impairments in communication, restricted interests and repetitive behavior. Other aspects, such as atypical eating, are also common but are not essential for diagnosis. Individual symptoms of autism occur in the general population and appear not to associate highly, without a sharp line separating pathological severity from common traits.

### Physical examination

[edit | edit source]

Physical examination of patients with autism is usually remarkable for repetitive behavior, dyspraxia, abnormal gait, and abnormality of motor functions. The signs of autism are present since birth but initial signs are visible by the age of 6-12 months. Most of the clinical signs of autism are identified by three years of age.

### Laboratory Findings

[edit | edit source]

Clinical genetics evaluations are often done once ASD is diagnosed, particularly when other symptoms already suggest a genetic cause. Although genetic technology allows clinical geneticists to link an estimated 40% of cases to genetic causes,[6] consensus guidelines in the U.S. and UK are limited to high-resolution chromosome and fragile X testing. As new genetic tests are developed several ethical, legal, and social issues will emerge. Commercial availability of tests may precede adequate understanding of how to use test results, given the complexity of autism's genetics.[7] Metabolic tests are sometimes helpful, but are not routine.

### CT

[edit | edit source]

There are no CT scan findings associated with autism

### MRI

[edit | edit source]

There are no MRI findings associated with autism

### Other Diagnostic studies

[edit | edit source]

Other diagnostic studies for autism include electroencephalography, polysomnography, metabolic testing, and genetic testing to rule out other conditions.

### Other imaging studies

[edit | edit source]

Positron emission tomography (PET scan), single-photon emission CT scanning (SPECT) may show some deficits, but these findings are nonspecific to diagnose autism spectrum disorder

## Treatment

[edit | edit source]

### Medical Therapy

[edit | edit source]

Many medications are used to treat problems associated with ASD.[8] More than half of U.S. children diagnosed with ASD are prescribed psychoactive drugs or anticonvulsants, with the most common drug classes being antidepressants, stimulants, and antipsychotics.[9] Aside from antipsychotics,[10] there is scant reliable research about the effectiveness or safety of drug treatments for adolescents and adults with ASD.[11] A person with ASD may respond atypically to medications, the medications can have adverse effects, and no known medication relieves autism's core symptoms of social and communication impairments.[12][13]

### Behavorial Therapy

[edit | edit source]

The main goals of treatment are to lessen associated deficits and family distress, and to increase quality of life and functional independence. No single treatment is best and treatment is typically tailored to the child's needs. Intensive, sustained special education programs and behavior therapy early in life can help children acquire self-care, social, and job skills,[14] and often improve functioning and decrease symptom severity and maladaptive behaviors;[15] claims that intervention by age two to three years is crucial[16] are not substantiated.

### Cost-Effectiveness of Therapy

[edit | edit source]

Treatment is expensive; indirect costs are more so. A U.S. study estimated an average cost of $3.2 million in 2003 U.S. dollars for someone born in 2000, with about 10% medical care, 30% extra education and other care, and 60% lost economic productivity.[17] Publicly supported programs are often inadequate or inappropriate for a given child, and unreimbursed out-of-pocket medical or therapy expenses are associated with likelihood of family financial problems;[18] a 2008 U.S. study found a 14% average loss of annual income in families of children with ASD.[19] After childhood, key treatment issues include residential care, job training and placement, sexuality, social skills, and estate planning.[20]

## References

[edit | edit source]

1. ↑ Penn HE (2006). "Neurobiological correlates of autism: a review of recent research". Child Neuropsychol. 12 (1): 57–79. doi:10.1080/09297040500253546. PMID 16484102.
2. ↑ Trottier G, Srivastava L, Walker CD (1999). "Etiology of infantile autism: a review of recent advances in genetic and neurobiological research". J Psychiatry Neurosci. 24 (2): 103–115. PMID 10212552. Retrieved 2007-07-16.CS1 maint: Multiple names: authors list (link)
3. ↑ Freitag CM (2007). "The genetics of autistic disorders and its clinical relevance: a review of the literature". Mol Psychiatry. 12 (1): 2–22. doi:10.1038/sj.mp.4001896. PMID 17033636.
4. ↑ Arndt TL, Stodgell CJ, Rodier PM (2005). "The teratology of autism". Int J Dev Neurosci. 23 (2–3): 189–99. doi:10.1016/j.ijdevneu.2004.11.001. PMID 15749245.CS1 maint: Multiple names: authors list (link)
5. ↑ Rutter M (2005). "Incidence of autism spectrum disorders: changes over time and their meaning". Acta Paediatr. 94 (1): 2–15. PMID 15858952.
6. ↑ Schaefer GB, Mendelsohn NJ (2008). "Genetics evaluation for the etiologic diagnosis of autism spectrum disorders". Genet Med. 10 (1): 4–12. doi:10.1097/GIM.0b013e31815efdd7. PMID 18197051. Lay summary - Medical News Today (2008-02-07).
7. ↑ McMahon WM, Baty BJ, Botkin J (2006). "Genetic counseling and ethical issues for autism". Am J Med Genet C Semin Med Genet. 142C (1): 52–7. doi:10.1002/ajmg.c.30082. PMID 16419100.CS1 maint: Multiple names: authors list (link)
8. ↑ Leskovec TJ, Rowles BM, Findling RL (2008). "Pharmacological treatment options for autism spectrum disorders in children and adolescents". Harv Rev Psychiatry. 16 (2): 97–112. doi:10.1080/10673220802075852. PMID 18415882.CS1 maint: Multiple names: authors list (link)
9. ↑ Oswald DP, Sonenklar NA (2007). "Medication use among children with autism spectrum disorders". J Child Adolesc Psychopharmacol. 17 (3): 348–55. doi:10.1089/cap.2006.17303. PMID 17630868.
10. ↑ Posey DJ, Stigler KA, Erickson CA, McDougle CJ (2008). "Antipsychotics in the treatment of autism". J Clin Invest. 118 (1): 6–14. doi:10.1172/JCI32483. PMID 18172517.CS1 maint: Multiple names: authors list (link)
11. ↑ Lack of research on drug treatments:
* Angley M, Young R, Ellis D, Chan W, McKinnon R (2007). "Children and autism—part 1—recognition and pharmacological management" (PDF). Aust Fam Physician. 36 (9): 741–4. PMID 17915375.CS1 maint: Multiple names: authors list (link)
* Broadstock M, Doughty C, Eggleston M (2007). "Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder". Autism. 11 (4): 335–48. doi:10.1177/1362361307078132. PMID 17656398.CS1 maint: Multiple names: authors list (link)
12. ↑ Template:Cite paper
13. ↑ Buitelaar JK (2003). "Why have drug treatments been so disappointing?". Novartis Found Symp. 251: 235–44, discussion 245–9, 281–97. doi:10.1002/0470869380.ch14. PMID 14521196.
14. ↑ Myers SM, Johnson CP, Council on Children with Disabilities (2007). "Management of children with autism spectrum disorders". Pediatrics. 120 (5): 1162–82. doi:10.1542/peds.2007-2362. PMID 17967921. Lay summary - AAP (2007-10-29).CS1 maint: Multiple names: authors list (link)
15. ↑ Rogers SJ, Vismara LA (2008). "Evidence-based comprehensive treatments for early autism". J Clin Child Adolesc Psychol. 37 (1): 8–38. doi:10.1080/15374410701817808. PMID 18444052.
16. ↑ Pettus A (2008). "A spectrum of disorders". Harv Mag. 110 (3): 27–31, 89–91.
17. ↑ Ganz ML (2007). "The lifetime distribution of the incremental societal costs of autism". Arch Pediatr Adolesc Med. 161 (4): 343–9. PMID 17404130. Lay summary - Harvard School of Public Health (2006-04-25).
18. ↑ Sharpe DL, Baker DL (2007). "Financial issues associated with having a child with autism". J Fam Econ Iss. 28 (2): 247–64. doi:10.1007/s10834-007-9059-6.
19. ↑ Montes G, Halterman JS (2008). "Association of childhood autism spectrum disorders and loss of family income". Pediatrics. 121 (4): e821–6. doi:10.1542/peds.2007-1594. PMID 18381511.
20. ↑ Aman MG (2005). "Treatment planning for patients with autism spectrum disorders". J Clin Psychiatry. 66 (Suppl 10): 38–45. PMID 16401149.

Template:WH Template:WS